Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 229-713-7 | CAS number: 6674-22-2
Endpoint summary
Administrative data
Description of key information
Acute toxicity (oral): LD50 rat = 215-681 mg/kg (OECD 401)
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 215 mg/kg bw
Additional information
Ingestion of DBU causes a worsening of the general state of health, dyspnoea, apathy, instability, tremor, cough, cyanosis, exophthalmos, atony, paresis.
Bibliographic source:
REACH Registration Dossier, 1,8-diazabicyclo[5.4.0]undec-7-ene
Justification for classification or non-classification
The substance is classified as toxic if swallowed. (CLP Regulation - category 3)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
